Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
lung cancer
Legend Biotech small cell lung cancer drug gets FDA ok for clinical development
Legend Biotech Corporation has announced that the U.S. Food and Drug Administration (FDA) has cleared…
November 21, 2022 - 2 minutes
Immutep announces efti clinical results for non-small cell lung cancer
Immutep Limited has revealed what it says are compelling new clinical data from its TACTI-002…
November 16, 2022 - 3 minutes
New approaches beckon for small cell lung cancer treatment
Small cell lung cancer (SCLC) is a particularly aggressive tumor that has so far been…
October 6, 2022 - 3 minutes
FDA fast tracks Immutep non-small cell lung cancer candidate
Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track…
October 5, 2022 - 3 minutes
Himalaya Therapeutics publishes data on cancer treatment
Himalaya Therapeutics has given an interim topline data update from its phase 2 study of…
September 13, 2022 - 3 minutes
PDC*line Pharma presents results from phase I/II trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable…
September 12, 2022 - 3 minutes
Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer
Patients with advanced EGFRm+ non-small cell lung cancer (NSCLC) with central nervous system (CNS) metastases…
August 25, 2022 - 3 minutes
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
August 24, 2022 - 2 minutes
Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
August 8, 2022 - 3 minutes
Evaxion Biotech picks candidate for lung cancer trial
A clinical-stage biotech company that specializes in developing AI-driven immunotherapies has chosen its product candidate…
June 23, 2022 - 2 minutes
